Titan Biotech Limited (TITANBIO.BO)
INR 456.8
(-0.87%)
INR 456.8
(-0.87%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 884.66 Million INR | -17.13% |
| 2022 | 741.26 Million INR | -4.89% |
| 2021 | 779.33 Million INR | 16.4% |
| 2020 | 669.53 Million INR | 110.54% |
| 2019 | 318 Million INR | 29.61% |
| 2018 | 245.34 Million INR | 29.74% |
| 2017 | 189.1 Million INR | 51.14% |
| 2016 | 125.11 Million INR | 5.83% |
| 2015 | 118.22 Million INR | 15.63% |
| 2014 | 102.24 Million INR | 15.2% |
| 2013 | 88.74 Million INR | 24.63% |
| 2012 | 71.21 Million INR | 23.8% |
| 2011 | 57.51 Million INR | -9.33% |
| 2010 | 63.43 Million INR | 82.37% |
| 2009 | 34.78 Million INR | 22.22% |
| 2008 | 28.45 Million INR | -22.85% |
| 2007 | 36.88 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 140.29 Million INR | 0.29% |
| 2023 Q2 | 222.05 Million INR | 10.03% |
| 2023 Q1 | 201.81 Million INR | 3.67% |
| 2023 Q4 | 139.88 Million INR | -42.78% |
| 2023 FY | 614.24 Million INR | -17.13% |
| 2023 Q3 | 244.46 Million INR | 10.1% |
| 2022 Q3 | 164.01 Million INR | -19.98% |
| 2022 Q4 | 194.67 Million INR | 18.69% |
| 2022 FY | 741.26 Million INR | -4.89% |
| 2022 Q1 | 177.59 Million INR | 143.89% |
| 2022 Q2 | 204.97 Million INR | 15.41% |
| 2021 Q1 | 221.19 Million INR | 271.48% |
| 2021 FY | 779.33 Million INR | 16.4% |
| 2021 Q2 | 201.17 Million INR | -9.05% |
| 2021 Q3 | 177.91 Million INR | -11.56% |
| 2021 Q4 | 72.81 Million INR | -59.07% |
| 2020 FY | 669.53 Million INR | 110.54% |
| 2020 Q2 | 184.63 Million INR | -26.97% |
| 2020 Q3 | 178.05 Million INR | -3.56% |
| 2020 Q4 | 59.54 Million INR | -66.56% |
| 2020 Q1 | 252.8 Million INR | 859.11% |
| 2019 FY | 318 Million INR | 29.61% |
| 2019 Q1 | 102.87 Million INR | 15.6% |
| 2019 Q2 | 90.99 Million INR | -11.55% |
| 2019 Q3 | 97.76 Million INR | 7.45% |
| 2019 Q4 | 26.35 Million INR | -73.04% |
| 2018 Q3 | 72.63 Million INR | -19.86% |
| 2018 Q4 | 88.99 Million INR | 22.52% |
| 2018 Q2 | 90.63 Million INR | 14.58% |
| 2018 Q1 | 79.1 Million INR | 85.15% |
| 2018 FY | 245.34 Million INR | 29.74% |
| 2017 Q3 | 44.52 Million INR | -3.57% |
| 2017 FY | 189.1 Million INR | 51.14% |
| 2017 Q4 | 42.72 Million INR | -4.06% |
| 2017 Q2 | 46.17 Million INR | 14.13% |
| 2017 Q1 | 40.46 Million INR | 1.75% |
| 2016 Q4 | 39.76 Million INR | -24.98% |
| 2016 FY | 125.11 Million INR | 5.83% |
| 2016 Q1 | 30.76 Million INR | 1017.57% |
| 2016 Q3 | 53 Million INR | 21.2% |
| 2016 Q2 | 43.73 Million INR | 42.18% |
| 2015 FY | 118.22 Million INR | 15.63% |
| 2015 Q4 | -3.35 Million INR | -108.02% |
| 2015 Q3 | 41.77 Million INR | -3.43% |
| 2015 Q2 | 43.26 Million INR | 24.11% |
| 2015 Q1 | 34.85 Million INR | 542.13% |
| 2014 Q1 | 32.1 Million INR | 721.16% |
| 2014 FY | 102.24 Million INR | 15.2% |
| 2014 Q3 | 40.42 Million INR | 7.54% |
| 2014 Q2 | 37.59 Million INR | 17.11% |
| 2014 Q4 | -7.88 Million INR | -119.5% |
| 2013 Q2 | 34.93 Million INR | 48.55% |
| 2013 Q4 | -5.16 Million INR | -114.58% |
| 2013 Q1 | 23.52 Million INR | 291.35% |
| 2013 Q3 | 35.45 Million INR | 1.49% |
| 2013 FY | 88.74 Million INR | 24.63% |
| 2012 Q4 | 6.01 Million INR | -74.08% |
| 2012 Q1 | 19.15 Million INR | 2.16% |
| 2012 Q2 | 22.86 Million INR | 19.41% |
| 2012 Q3 | 23.18 Million INR | 1.38% |
| 2012 FY | 71.21 Million INR | 23.8% |
| 2011 Q4 | 18.74 Million INR | -3.9% |
| 2011 Q3 | 19.5 Million INR | 0.0% |
| 2011 FY | 57.51 Million INR | -9.33% |
| 2010 Q4 | 16.33 Million INR | 0.0% |
| 2010 FY | 63.43 Million INR | 82.37% |
| 2009 FY | 34.78 Million INR | 22.22% |
| 2008 FY | 28.45 Million INR | -22.85% |
| 2008 Q4 | 11.91 Million INR | 0.0% |
| 2007 FY | 36.88 Million INR | 0.0% |
| 2007 Q4 | 10.37 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 10.46 Million INR | -8356.744% |
| Biocon Limited | 91.73 Billion INR | 99.036% |
| Blue Jet Healthcare Limited | 3.15 Billion INR | 71.997% |
| Concord Biotech Limited | 6.11 Billion INR | 85.524% |
| Dishman Carbogen Amcis Limited | 4.9 Billion INR | 81.96% |
| FERMENTA BIOTECH LIMITED | 1.82 Billion INR | 51.45% |
| GENOMIC VALLEY BIOTECH LIMITED | 1.65 Million INR | -53491.398% |
| Lyka Labs Limited | 145.95 Million INR | -506.131% |
| Panacea Biotec Limited | 1.35 Billion INR | 34.725% |
| SAMSRITA LABS LIMITED | -1.28 Million INR | 69048.693% |
| Servoteach Industries Limited | - INR | -Infinity% |
| SMS Lifesciences India Limited | 329.57 Million INR | -168.424% |
| Supriya Lifescience Limited | 2.65 Billion INR | 66.639% |
| Syngene International Limited | 12.43 Billion INR | 92.887% |
| TAKE Solutions Limited | 183.42 Million INR | -382.314% |
| Transgene Biotek Limited | -1.69 Million INR | 52384.87% |
| Vanta Bioscience Limited | 7.12 Million INR | -12325.0% |